A randomized, double blind trial of LdT (telbivudine) versus lamivudine in adults with compensated chronic hepatitis B
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2015
At a glance
- Drugs Telbivudine (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- Acronyms GLOBE
- Sponsors Idenix Pharmaceuticals; Merck Sharp & Dohme
- 01 Feb 2009 2-year results published in Gastroenterology.
- 20 Dec 2007 Week 52 results published in full in New England Journal of Medicine (NEJM) 357: 2576-2588, No. 25, 20 Dec 2007.
- 27 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History